HM15136 (Efpegerglucagon)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HM15136 (Efpegerglucagon), covering 2025-01-27 to 2025-02-05. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136(Efpegerglucagon) in Healthy Subjects [Phase 1]